Neuropeptides and morphological changes in cisplatin-induced dorsal root ganglion neuronopathy

Experimental Neurology

Volumn 138, Issue 1, 1996, Pages 93-104

  Barajon, Isabella ^a   Bersani, Maurizio ^b   Quartu, Marina ^c   Del Fiacco, Marina ^c   Cavaletti, Guido ^a   Holst, Jens Juul ^b   Tredici, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CISPLATIN; GALANIN; SOMATOSTATIN; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD; SPINAL GANGLION;

EID: 0029871951     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0050     Document Type: Article

References (53)

1. APFEL, S. C., J. C. AREZZO, L. A. LIPSON, AND J. A. KESSLER. 1992. Nerve growth factor prevents experimental cisplatin neuropathy. Ann. Neurol. 31: 76-80.
2. ASHRAF, M., J. E. RIGGS, S. WEARDEN, AND P. SCOTCHEL. 1990. Prospective study of nerve conduction parameters and serum magnesium following cisplatin therapy. Gynecol. Oncol. 37: 29-33.
3. BOOGERD, W., W. W. BOKKEL HUININK, O. DALESIO, W. J. J. F. HOPPENBROUWERS, AND J. VAN DER SANDE. 1990. Cisplatin induced neuropathy: Central, peripheral and autonomic nerve involvement. J. Neurol. Oncol. 9: 255-263.
4. BROMAN, J. 1994. Neurotransmitters in subcortical somatosensory pathways. Anat. Embryol. 189:181-214.
5. CAVALETTI, G., G. TREDICI, G. PIZZINI, AND A. MINOIA. 1990. Tissue platinum concentration and cisplatin schedules. Lancet 236: 1003.
6. CAVALETTI, G., M. G. PETRUCCIOLI, G. TREDICI, P. MARMIROLI, I. BARAJON, D. FABBRICA, AND A. DI FRANCESCO. 1991. Effects of repeated administration of low doses of cisplatin on the rat nervous system. Int. J. Tissue React. 13: 151-157.
7. CAVALETTI, G., L. MARZORATI, G. BOGLIUN, N. COLOMBO, M. MARZOLA, M. R. PITTELLI, AND G. TREDICI. 1992. Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single dose intensity. Cancer 69: 203-207.
8. CAVALETTI, G., P. TREDICI, P. MARMIROLI, M. G. PETRUCCIOLI, I. BARAJON, AND D. FABBRICA. 1992. Morphometric study of the sensory neurones and peripheral nerve changes induced by chronic cisplatin (DDP) administration. Acta Neuropathol. 84: 364-371.
9. CAVALETTI, G., C. MINOIA, M. SCHIEPPATI, AND G. TREDICI. 1994. Protective effects of glutathione on cisplatin neurotoxicity in rats. Int. J. Radiat. Oncol. Biol. Phys. 29: 771-776.
10. CAVALETTI, G., G. TREDICI, P. MARMIROLI, D. FABBRICA, AND M. BRAGA. 1994. Off-treatment course of cisplatin-induced dorsal root ganglia neuronopathy in rats. In Vivo 8: 313-316.
11. CAVALETTI, G., G. TREDICI, M. BRAGA, AND S. TAZZARI. 1995. Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol. Exp. Neurol. 133: 64-72.
12. COONS, A. H., AND M. H. KAPLAN. 1950. Localization of antigens in tissue cells. II. An improvement in a method for the detection of antigens by means of fluorescent antibody. J. Exp. Med. 91: 1-9.
13. DAUGAARD, G. K., J. PETRERA, AND W. TROJABORG. 1987. Electrophysiological study of the peripheral and central neurotoxic effect of cis-platin. Acta Neurol. Scand. 76: 86-93.
14. DALSGAARD, C.-J. 1988. The sensory system. Pages 599-636 in A. Björklund, T. Hökfelt, and C. Owmann, Eds., Handbook of Chemical Neuroanatomy, Vol. 6, The Peripheral Nervous System. Elsevier, Amsterdam/New York.
15. DE KÖNIG, P., J. P. NEIJT, F. G. JENNEKENS, AND W. H. GISPEN. 1987. Evaluation of cis-diammine dichloroplatinum (II) (cisplatin) neurotoxicity in rats. Toxicol. Appl. Pharmacol. 89: 81-87.
16. DEL FIACCO, M., AND M. QUARTU. 1994. Somatostatin, galanin, and peptide histidine isoleucine in the newborn and adult human trigeminal ganglion and spinal nucleus: Immunohistochemistry, neuronal morphometry and colocalization with substance P. J. Chem. Neuroanat. 7:171-184.
17. GASTAUT, J. L., AND J. F. PELLISSIER. 1985. Neuropathie au cisplatine. Etude clinique, electrophysiologique et morfologique. Rev. Neurol. (Paris) 141: 614-626.
18. GRANT, G. 1985. Primary afferent projections to the spinal cord. Pages 303-307 in G. Paxinos, Ed., The Rat Nervous System, Vol. 2. Academic Press, Sidney.
19. HADLEY, D., AND H. W. HERR. 1979. Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment. Cancer 44: 2026-2028.
20. HARMAR, A., AND P. KEEN. 1982. Synthesis, and central and peripheral axonal transport of substance P in a dorsal root ganglion-nerve preparation in vitro. Brain Res. 231: 379-386.
21. HARPER, A. A., AND S. N. LAWSON. 1985. Conduction velocity is related to cell type in rat dorsal root ganglion neurones. J. Physiol. 359: 31-46.
22. HEGEDUS, L., W. J. F. VAN DER VIJGH, I. KLEIN, S. KERPELFRONIUS, AND H. M. PINEDO. 1987. Chemical reactivity of cisplatin bound to human plasma proteins. Cancer Chemother. Pharmacol. 20: 211-212.
23. HILSTED, L., AND J. J. HOLST. 1982. On the accuracy of radioimmunological determination of somatostatin in plasma. Regul. Peptides 4: 12-31.
24. HOLST, J. J., AND M. BERSANI. 1991. Assays for peptide products of somatostatin gene expression. Pages 3-22 in Methods in Neuroscience, Vol. 5. Academic Press, San Diego.
25. HOKFELT, T., X. ZHANG, AND Z. WIESENFELD-HALLIN. 1994. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 17: 22-30.
26. ISHIDA-YAMAMOTO, A., AND E. SENBA. 1990. Cell types and axonal sizes of calcitonin gene-related peptide-containing primary sensory neurons of the rat. Brain Res. Bull. 24: 759-764.
27. JENNEKENS, F. G. I. 1987. Peripheral neuropathy in renal and hepatic insufficiency. Pages 355-366. in P. J. Vinken, G. W. Bruyn, and H. L. Klawans, Eds., Handbook of Clinical Neurology, Vol. 51. Elsevier, Amsterdam.
28. JU, G., T. HÜKFELT, E. BRODIN, J. FAHRENKRUG, J. A. FISCHER, P. FREY, R. P. ELDE, AND J. C. BROWN. 1987. Primary sensory neurones of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells. Cell Tissue Res. 247: 417-431.
29. KEDAR, A., M. E. COHEN, AND A. I. FREEMAN. 1978. Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum (II) treatment: A case report. Cancer Treat. Rep. 62: 819-821.
30. LEVI, J., C. JACOBS, S. M. KALMAN, M. MCTINGUE, AND M. W. WEINER. 1980. Mechanisms of cisplatinum nephrotoxicity. 2. Effects of sulphydryl groups in rat kidneys. Pharmacol. Exp. Ther. 213: 545-550.
31. LIPPARD, S. J. 1982. New chemistry of an old molecule. Science 218: 1075-1085.
32. 4-9. Peripheral Nerve Soc. Congr., p. 132, Saint Paul, MN. [Abstract].
33. MESSEL, T., H. HARLING, G. BÖTTCHER, A. H. JOHNSEN, AND J. J. HOLST. 1990. Galanin in the porcine pancreas. Regul. Peptides 28: 161-176.
34. MOLLMAN, J. E. 1990. Cisplatin neurotoxicity. N. Engl. J. Med. 322: 126-127.
35. MULLER, L. J., R. GERRITSEN VAN DER HOOP, C. MOORER VAN DELFT, AND Y. OLSSON. 1984. Vascular permeability in the peripheral nervous system. Pages 579-597 in P. J. Dyck, P. K. Thomas, E. H. Lambert, and R. Bunge, Eds., Peripheral Neuropathy, 2nd ed. Saunders, Philadelphia.
36. NEWGARD, C. B., AND J. J. HOLST. 1981. Heterogeneity of somatostatin-like immunoreactivity (SLI) in extracts of porcine, canine and human pancreas. Acta Endocrinol. (Copenhagen) 98: 564-572.
37. PARTI, R., AND W. WOLF. 1990. Quantitative subcellular distribution of platinum in rats tissues following i.v. bolus and i.v. infusion of cisplatin. Cancer Chemother. Pharmacol. 26: 188-192.
38. PLENDERLEITH, M. B., C. J. HALLER, AND P. J. SNOW. 1990. Peptide coexistence in axon terminals within the superficial dorsal horn of the rat spinal cord. Synapse 6: 344-350.
39. RASMUSSEN, T. N., M. BERSANI, A. H. JOHNSEN, H. KOFOD, AND J. J. HOLST. 1994. Pigs produce only a single form of CGRP, part of which is processed to N- and C-terminal fragments. Peptides 15: 89-94.
40. RIGGS, J. E., M. ASHRAF, R. D. SNYDER, AND L. GUTMANN. 1988. Prospective nerve conduction studies in cisplatin therapy. Ann. Neurol. 23: 92-94.
41. ROELOFS, R. I., W. HRUSHESKY, J. ROGIN, AND L. ROSENBERG. 1984. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 34: 934-938.
42. ROSENBERG, B. 1985. Fundamental studies with cisplatin. Cancer 55: 2303-2316.
43. RUDA, M. A., G. J. BENNET, AND R. DUBNER. 1986. Neurochemistry and neural circuitry in the dorsal horn. Prog. Brain Res. 66: 219-268.
44. SCHMIDT, Y., J. W. UNGER, I. BARTKE, AND R. REITER 1995. Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice. Exp. Neurol. 132: 16-23.
45. SCHMIDT, P., S. S. POULSEN, T. N. RASMUSSEN, M. BERSANI, AND J. J. HOLST. 1991. Substance P and neurokinin A are codistributed and colocalized in the porcine gastrointestinal tract. Peptides 12: 963-973.
46. SPENCER, P. S., AND H. H. SCHAUMBURG. 1984. Experimental models of primary axonal disease induced by toxic chemicals. Pages 636-649 in P. J. Dyck, P. K. Thomas, E. H. Lambert, and R. Bunge, Eds., Peripheral Neuropathy, 2nd ed. Saunders, Philadelphia.
47. TAY, L. K., C. L. BREGMAN, B. A. MASTERS, AND P. D. WILLIAMS. 1988. Effects of cis-diamminedichloroplatinum (II) on rabbit kidney in vivo and on rabbit renal proximal tubule cells in culture. Cancer Res. 48: 2538-2543.
48. TERHEGGEN, P. M. A. B., R. GERRITSEN VAN DER HOOP, B. G. J. FLOOT, AND W. H. GISPEN. 1989. Cellular distribution of cis-diammine-dichloroplatinum (II)-DNA binding in rat dorsal root spinal ganglia: Effect of the neuroprotecting peptide Org. 2766. Toxicol. Appl. Pharmacol. 99: 334-343.
49. THOMPSON, S. W., L. E. DAWIS, M. KORNFIELD, R. D. HILGERS, AND J. C. STANDEFER 1984. Cisplatin neuropathy: Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 54: 1269-1275.
50. TOMIWA, K., C. NOLAN, AND J. B. CAVANAGH. 1986. The effect of cisplatin on the rat spinal ganglia: A study by light and electron microscopy and by morphometry. Acta Neuropathol. (Berlin) 69: 295-308.
51. VILLAR, M. J., R. CORTÉS, E. THEODORSSON, Z. WIESENFELD-HALLIN, M. SCHALLING, J. FAHRENKRUG, P. C. EMSON, AND T. HÖKFELT. 1989. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience 33: 587-604.
52. VILLAR, M. J., Z. WIESENFELD-HALLIN, X.-J. XU, E. THEODORSSON, P. C. EMSON, AND T. HÖKFELT. 1991. Further studies on galanin-, substance P-, and CGRP-like immunoreactivities in primary sensory neurones and spinal cord: Effects of dorsal rhizotomies and sciatic nerve lesions. Exp. Neurol. 112: 29-39.
53. WALTHER, P. J., E. ROSBITCH, AND D. E. BULLARD. 1987. The development of Lhermitte's sign during cisplatin chemotherapy. Cancer 60: 2170-2172.